| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |